Normative Modeling of Structural and Diffusion MRI for Epilepsy Diagnosis and Classification

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background and Objectives

Normative modeling expresses an individual’s brain measures as deviations from a large healthy reference and has been advanced as a route to precision imaging biomarkers in epilepsy, where structural abnormality is distributed rather than confined to the presumed focus. Whether this framework can inform clinical classification from clinically acquired T1-weighted and diffusion MRI is untested. We asked whether normative deviations discriminate between (1) epilepsy and functional seizures; (2) focal and generalized epilepsy; and (3) drug-resistant and drug-responsive epilepsy.

Methods

We retrospectively studied patients with epilepsy or functional seizures without comorbid epilepsy who underwent 3-Tesla epilepsy-protocol MRI at the University of Pennsylvania. Morphometric deviation scores (cortical thickness, subcortical volume) were derived from CentileBrain ( n >37,000 healthy references). White matter fractional anisotropy and mean diffusivity profiles were referenced to harmonized Human Connectome Project cohorts. Lobar composites, hemispheric asymmetry indices, and whole-tract means were compared with rank-sum tests; discrimination was summarized as area under the ROC curve (AUC) with bootstrap confidence intervals and Benjamini-Hochberg correction. Whole-brain deviation burden was examined as a secondary analysis. Minimum detectable effects were estimated by Monte Carlo simulation at 80% power (α=0.05).

Results

We included 273 patients with epilepsy (203 focal, 37 generalized, 33 unclassified; 97 drug-resistant, 176 drug-responsive) and 32 with functional seizures. In the primary analyses, no regional or tract-level normative measure distinguished epilepsy from functional seizures, focal from generalized epilepsy, or drug-resistant from drug-responsive epilepsy; AUCs did not exceed 0.62, with upper confidence limits up to 0.72. In the secondary analysis, whole-brain morphometric deviation burden was modestly higher in epilepsy than in functional seizures (AUC 0.66, 95% CI 0.57-0.74) but did not separate the within-epilepsy comparisons. The study could detect AUC ≥0.65 for epilepsy versus functional seizures, ≥0.64 for focal versus generalized, and ≥0.60 for drug-resistant versus drug-responsive epilepsy.

Discussion

Univariate normative deviation summaries from clinical MRI do not currently distinguish these groups well enough to guide care. Whole-brain deviation burden, the only summary measure that differed after correction, was detectable at the group level but insufficient for individual-level classification. Progress may require network-targeted analysis of patient-specific deviations and multimodal integration.

Article activity feed